Veterinary pharmacy moves closer to specialty recognition

Veterinary pharmacy may be nearing a milestone that pharmacy leaders have pursued for years: formal board-specialty recognition for pharmacists who focus on animal health. The Board of Pharmacy Specialties is now reviewing a petition submitted in January 2026 by the American College of Veterinary Pharmacists, the International College of Veterinary Pharmacy, and the Society of Veterinary Hospital Pharmacists, and the public comment period opened February 26 with comments due by April 1, 2026. BPS says a prior job analysis supported continued review of the specialty proposal. (pharmacytimes.com)

That context matters because veterinary teams already work in a credential-heavy environment, but the credentials don’t all mean the same thing. AVMA policy distinguishes board certification by an AVMA-recognized veterinary specialty organization from certificate programs or other educational credentials. In other words, when Clinician’s Brief asks whether veterinary pharmacy should “become a specialty,” the answer depends on whose specialty framework is being discussed: veterinarians already have an AVMA-recognized specialty in veterinary clinical pharmacology through the American College of Veterinary Clinical Pharmacology, while pharmacists do not yet have parallel BPS board certification in veterinary pharmacy. (avma.org)

The push toward pharmacist specialty recognition has been building for at least two years. In July 2024, BPS called for subject matter experts to participate in a veterinary pharmacy job analysis panel, saying the results would determine whether there was enough interest and practice definition to pursue a certification program. By fall 2025, ACVP and partner groups were publicly gathering survey support for a petition, describing specialty recognition as a way to standardize training and affirm pharmacists’ role in species-appropriate medication use. That sequence suggests the current petition is not a sudden idea, but the product of a structured credentialing process. (prnewswire.com)

The case being made by supporters is that veterinary pharmacy is meaningfully different from general pharmacy practice. In the petition summary cited by Pharmacy Times, proponents argue pharmacists are uniquely licensed to provide pharmaceutical care across human and nonhuman species, but that animal care brings distinct scientific, regulatory, and ethical complexities. ACVP’s public materials frame those differences around comparative pharmacology, toxicology, zoonotic disease prevention, and food-chain safety. The Society of Veterinary Hospital Pharmacists also emphasizes that its members work in veterinary teaching hospitals and institutional settings where pharmacists are involved in product selection, procurement, teaching, and research, underscoring that this is already an established practice niche even if it lacks broad board-recognition. (pharmacytimes.com)

That broader framing also fits with how the profession increasingly talks about veterinary impact beyond the exam room. Clinician’s Brief recently highlighted global data mapping travel time to veterinary care across 300,000 practices in 115 countries, using access as a lens for public health, food security, and animal welfare. A pharmacy specialty obviously would not solve geographic access gaps, but supporters’ One Health argument lands differently in that context: medication expertise in animals is part of the same larger ecosystem of zoonotic disease prevention, food-animal stewardship, and safe, effective care delivery. (vetmeds.org)

Industry coverage has generally been favorable. Pharmacy Times described the petition as a step toward creating a formal pathway where none currently exists for pharmacists, contrasting that gap with the more defined residency and examination route veterinarians follow in veterinary clinical pharmacology. The same reporting noted that veterinary pharmacy has already gained recognition at the pharmacy technician level through a veterinary pharmacy certificate, reinforcing the argument from supporters that pharmacist credentialing has lagged behind practice needs. (pharmacytimes.com)

The timing also overlaps with a period when veterinary medicine is paying closer attention to economics, specialization, and the complexity of modern therapeutics. Clinician’s Brief recently discussed the shifting debt-to-income picture for new DVMs, a reminder that practices are making staffing and workflow decisions under real financial pressure. At the same time, new treatment categories such as monoclonal antibodies are expanding in dermatology, pain management, and other areas, increasing the need for species-specific medication knowledge and careful client guidance. Even antimicrobial stewardship conversations, including interest in “wait-and-see” prescribing strategies in human medicine, point back to the same core issue: medication decisions in veterinary practice are getting more nuanced, not less.

Why it matters: For veterinarians, this is less about title inflation and more about medication quality, safety, and workflow. A recognized veterinary pharmacy specialty could make it easier to identify pharmacists with deeper expertise in species-specific dosing, extemporaneous compounding, controlled substance and prescribing rules, client adherence challenges, and the practical realities of sourcing and dispensing animal medications. That could be especially relevant as companion animal therapeutics grow more complex, compounding remains common, and practices continue to rely on outside pharmacies that may or may not understand veterinary prescribing nuances. It may also matter more as newer drug classes, including monoclonal antibodies, become a larger part of everyday care and as stewardship-minded prescribing requires more precise communication with clients. At the same time, because this would be a pharmacy-board credential rather than an AVMA veterinary specialty, practices will need to understand exactly what the designation does, and doesn’t, signal. (pharmacytimes.com)

There’s also a broader workforce angle. ACVP is actively expanding conference programming, student activities, and public-facing pharmacy locator tools, all signs that veterinary pharmacy is trying to build a more visible professional pipeline. If BPS approves the petition, the next phase would be operational: a specialty council would define eligibility and exam content, which is where questions about training routes, experience thresholds, and real-world practice standards will become more concrete. In a profession already thinking hard about workforce access, educational cost, and how to deploy expertise efficiently, those details may matter as much as the approval itself. (vetmeds.org)

What to watch: The immediate next step is BPS’s decision, which ACVP says should come within six months of the public comment period. If the petition is approved, watch for details on eligibility criteria, exam development, and how quickly employers, veterinary hospitals, and referral practices begin treating the credential as a meaningful marker of advanced pharmacy support in animal health. It will also be worth watching whether the specialty is framed mainly around hospital and referral practice, or more broadly around the medication challenges general practice teams face every day. (vetmeds.org)